These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2420968)

  • 41. Development of digoxigenin-labeled peptide: application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues.
    Décarie A; Drapeau G; Closset J; Couture R; Adam A
    Peptides; 1994; 15(3):511-8. PubMed ID: 7937327
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carboxypeptidase B inhibitors reduce tissue factor-induced renal microthrombi in rats.
    Muto Y; Suzuki K; Sato E; Ishii H
    Eur J Pharmacol; 2003 Feb; 461(2-3):181-9. PubMed ID: 12586213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of bradykinin generating and degrading systems in the vascular permeability response induced with kaolin in rats.
    Kumakura S; Kamo I; Tsurufuji S
    Adv Exp Med Biol; 1989; 247B():541-6. PubMed ID: 2610091
    [No Abstract]   [Full Text] [Related]  

  • 44. A sensitive method for differential determination of kininase I, II and neutral endopeptidase (NEP) in human urine.
    Ogata H; Ura N; Shimamoto K; Sakakibara T; Ando T; Nishimiya T; Nakagawa M; Fukuyama S; Masuda A; Yamaguchi Y
    Adv Exp Med Biol; 1989; 247B():343-8. PubMed ID: 2558508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood pressure response to bolus administration of vasoactive drugs in the rat.
    Vacek L; Bravený P
    Physiol Bohemoslov; 1978; 27(1):37-41. PubMed ID: 25448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design of potent and specific inhibitors of carboxypeptidases A and B.
    Ondetti MA; Condon ME; Reid J; Sabo EF; Cheung HS; Cushman DW
    Biochemistry; 1979 Apr; 18(8):1427-30. PubMed ID: 427123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of bradykinin in the vascular permeability response induced by carrageenin in rats.
    Kumakura S; Kamo I; Tsurufuji S
    Br J Pharmacol; 1988 Apr; 93(4):739-46. PubMed ID: 2839262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Bradykinin-binding cell fractions. 3. Methods for determination of enzymatic degradation of bradykinin with kininase from plasma membranes].
    Leisner H; Reissmann S; Arold H
    Pharmazie; 1978 Aug; 33(8):531-3. PubMed ID: 724786
    [No Abstract]   [Full Text] [Related]  

  • 49. Endotoxin-induced impairment of vasodepressor responses in the pithed rat.
    Guc MO; Gray GA; Furman BL; Parratt JR
    Eur J Pharmacol; 1991 Oct; 204(1):63-70. PubMed ID: 1804663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Properties of kininase in rat dental pulp.
    Maita E; Endo Y; Ogura Y
    J Dent Res; 1984 Aug; 63(8):1067-71. PubMed ID: 6589267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological comparison of bPTH-(1-34) and other hypotensive peptides in the dog.
    Tenner TE; Yang CM; Chang JK; Schimizu M; Pang PK
    Peptides; 1980; 1(4):285-8. PubMed ID: 6170959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The action of some vasoactive polypeptides and their antagonists on the anococcygeus muscle [proceedings].
    Gillespie JS; McKnight AT
    J Physiol; 1976 Sep; 260(2):19P-20P. PubMed ID: 978512
    [No Abstract]   [Full Text] [Related]  

  • 53. EXPERIMENTS ON THE IN VITRO INACTIVATION OF PLASMA KININS BY CARBOXYPEPTIDASE B, PLASMA KININASE OR ERYTHROCYTE KININASE IN THE PRESENCE OF DISULFIRAM.
    JENSEN KB; RINVIK SF; VENNEROED AM
    Acta Pharmacol Toxicol (Copenh); 1965; 22():187-95. PubMed ID: 14284197
    [No Abstract]   [Full Text] [Related]  

  • 54. Altered urinary excretion of human kininase activity in hypertension.
    Greco A; Porcelli G; Di Jorio M; Ranieri M; D'Acguarica L; Ranalli L
    Adv Exp Med Biol; 1979; 120B():645-9. PubMed ID: 517258
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidase N.
    Hendriks D; Scharpé S; van Sande M; Lommaert MP
    J Clin Chem Clin Biochem; 1989 May; 27(5):277-85. PubMed ID: 2760564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Interaction of immobilized carboxypeptidase with a natural inhibitor from human blood plasma].
    Trapeznikova SS; Gontar' ID
    Vopr Med Khim; 1977; (6):840-4. PubMed ID: 595489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regional distribution of kininase in rat brain.
    Kariya K; Kawauchi R; Okamoto H
    J Neurochem; 1981 Jun; 36(6):2086-8. PubMed ID: 6264046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purification and properties of microsomal carboxypeptidase N (kininase I) in human placenta.
    Ito Y; Mizutani S; Kurauchi O; Kasugai M; Narita O; Tomoda Y
    Enzyme; 1989; 42(1):8-14. PubMed ID: 2776715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A peptide derived from fibrin(ogen) inhibits angiotensin converting enzyme and potentiates the effects of bradykinin.
    Saldeen T; Ryan JW; Berryer P
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):465-70. PubMed ID: 6275568
    [No Abstract]   [Full Text] [Related]  

  • 60. 6-glycine-8-phenyllactic acid bradykinin. Its synthesis, biological activity, and splitting by kininase (carboxypeptidase N).
    Ravdel GA; Filatova MP; Shchukina LA; Paskhina TS; Surovikina MS; Trapeznikova SS; Egorova TP
    J Med Chem; 1967 Mar; 10(2):242-6. PubMed ID: 6034068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.